Literature DB >> 16758202

[Epidemiology and pathophysiology of overactive bladder].

S Schumacher1.   

Abstract

According to the new ICS classification overactive bladder (OAB) is defined as a complex of symptoms such as frequency, nocturia, and urgency with or without urge urinary incontinence. Urgency is the key symptom that leads to the diagnosis. The prevalence of overactive bladder in the general adult population is approximately 17%. This number increases with advancing age. Incontinence events are reported in approximately one-third of these patients. Symptoms of overactive bladder have a negative impact on quality of life in every second patient and on sexuality in every fourth patient. In addition to neurogenic and myogenic factors, nowadays urothelial dysfunction is being discussed in the etiology of OAB.

Entities:  

Mesh:

Year:  2006        PMID: 16758202     DOI: 10.1007/s00120-006-1076-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  10 in total

Review 1.  Antimuscarinics for treatment of overactive bladder.

Authors:  Karl-Erik Andersson
Journal:  Lancet Neurol       Date:  2004-01       Impact factor: 44.182

Review 2.  The urothelium in overactive bladder: passive bystander or active participant?

Authors:  William C de Groat
Journal:  Urology       Date:  2004-12       Impact factor: 2.649

Review 3.  Vesico-vaginal fistula.

Authors:  Christopher Chapple; Richard Turner-Warwick
Journal:  BJU Int       Date:  2005-01       Impact factor: 5.588

4.  Prevalence of the overactive bladder syndrome by applying the International Continence Society definition.

Authors:  Christian Temml; Stefan Heidler; Anton Ponholzer; Stephan Madersbacher
Journal:  Eur Urol       Date:  2005-10       Impact factor: 20.096

Review 5.  Smooth muscle of the bladder in the normal and the diseased state: pathophysiology, diagnosis and treatment.

Authors:  W H Turner; A F Brading
Journal:  Pharmacol Ther       Date:  1997-08       Impact factor: 12.310

6.  How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study.

Authors:  I Milsom; P Abrams; L Cardozo; R G Roberts; J Thüroff; A J Wein
Journal:  BJU Int       Date:  2001-06       Impact factor: 5.588

7.  Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group.

Authors:  J S Brown; E Vittinghoff; J F Wyman; K L Stone; M C Nevitt; K E Ensrud; D Grady
Journal:  J Am Geriatr Soc       Date:  2000-07       Impact factor: 5.562

Review 8.  Overactive bladder significantly affects quality of life.

Authors:  P Abrams; C J Kelleher; L A Kerr; R G Rogers
Journal:  Am J Manag Care       Date:  2000-07       Impact factor: 2.229

Review 9.  A neurologic basis for the overactive bladder.

Authors:  W C de Groat
Journal:  Urology       Date:  1997-12       Impact factor: 2.649

10.  Prevalence and burden of overactive bladder in the United States.

Authors:  W F Stewart; J B Van Rooyen; G W Cundiff; P Abrams; A R Herzog; R Corey; T L Hunt; A J Wein
Journal:  World J Urol       Date:  2002-11-15       Impact factor: 4.226

  10 in total
  3 in total

1.  [Etiology and pathogenesis of overactive bladder].

Authors:  T Bschleipfer; F Wagenlehner; W Weidner
Journal:  Urologe A       Date:  2011-04       Impact factor: 0.639

2.  [Treatment for overactive bladder].

Authors:  P Rothe; M Kalchthaler; S Mühlich
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

3.  [Trospium chloride once daily for overactive bladder syndrome: results of a multicenter observational study].

Authors:  H-J Notz; B Hautumm; D Werdier; R Groves; K P Odenthal
Journal:  Urologe A       Date:  2013-01       Impact factor: 0.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.